pharma stocks outlook: Dr Reddy’s, Zydus, Cipla, Sun can sustain low-double digit EPS growth over medium term: Bino Pathiparampil

by pulseadmin January 24, 2025, 2:11 pm 100 Views

Bino Pathiparampil, Head of Research, Elara Capital, says companies like Dr Reddy’s, Zydus, Cipla, Sun, can sustain a low-double digit EPS growth over the medium term. Low-double digit is 11%, 12%, 13%, for companies which are offering 12% to 13% earnings growth on a sustainable basis and…